| Miss Samantha Jo Mitchell, PHARMD | |
|
1375 E 10th St Suite B, Rolla, MO 65401 | |
| (573) 364-9616 | |
| Not Available |
| Full Name | Miss Samantha Jo Mitchell |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1375 E 10th St Suite B, Rolla, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639645591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2018026729 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Samantha Jo Mitchell, PHARMD Po Box 528, Cuba, MO 65453 Ph: (573) 885-0885 | Miss Samantha Jo Mitchell, PHARMD 1375 E 10th St Suite B, Rolla, MO 65401 Ph: (573) 364-9616 |
News Archive
A wireless monitoring system for people with debilitating conditions such as Parkinson's disease or chronic obstructive pulmonary disorder could allow healthcare workers to assess a patient's health and the development of their disease without hindering their movements. Details of the system are reported in the International Journal of Biomedical Engineering and Technology.
A research group at Lund University in Sweden has found that when the HLF (hepatic leukemia factor) gene -which is expressed in immature blood cells - does not shut down on time, we are unable to develop a functional long-term immune system. This could be a very early stage of leukemia.
The National Institute of Mental Health has selected The Lewin Group to perform a two-year study on health outcomes in children with autism and their families. The study will describe the range of medical conditions experienced by children with autism spectrum disorders and the health outcomes of the children and their families.
Eli Lilly and Company and Incyte Corporation announced today that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Incyte's oral JAK1/JAK2 inhibitor, INCB28050, and certain follow on compounds, for inflammatory and autoimmune diseases. The lead compound, INCB28050, is currently being studied in a six-month dose-ranging Phase II trial for rheumatoid arthritis.
The COVID pandemic has led to a significant increase in mental health problems. Now, in some good news, a pilot study has shown that depressed patients who have suffered from COVID respond better to standard antidepressants than do people who have not had COVID.
› Verified 3 days ago
Dr. Bryan Wesley Brooks, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1375 E 10th St Ste B, Rolla, MO 65401 Phone: 573-364-9616 Fax: 573-341-3986 | |
John L Keller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Hwy 72nd West Rolla, Hillcrest Shopping Ctr, Rolla, MO 65401 Phone: 573-364-3258 Fax: 573-341-2540 | |
Mr. Jeremy Helton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1003 S Bishop Ave, Rolla, MO 65401 Phone: 573-364-6079 | |
Ms. Sara E Trusler, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1605 Martin Springs Dr, Suite 220, Rolla, MO 65401 Phone: 573-458-6433 Fax: 573-458-6441 | |
Heather Nelson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1003 S Bishop Ave, Rolla, MO 65401 Phone: 573-364-6079 Fax: 573-364-6895 | |
Matthew Alexander, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 N Bishop Ave, Rolla, MO 65401 Phone: 573-308-4887 Fax: 573-308-8010 | |
Dr. Alynda Loughridge Bradley, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1605 Martin Springs Dr Ste 220b, Rolla, MO 65401 Phone: 573-458-6432 Fax: 573-458-6430 |